The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs
Open Access
- 1 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 32 (3), 636-647
- https://doi.org/10.1021/jasms.0c00379
Abstract
Protein mass spectrometry (MS) is an enabling technology that is ideally suited for precision diagnostics. In contrast to immunoassays with indirect readouts, MS quantifications are multiplexed and include identification of proteoforms in a direct manner. Although widely used for routine measurements of drugs and metabolites, the number of clinical MS-based protein applications is limited. In this paper, we share our experience and aim to take away the concerns that have kept laboratory medicine from implementing quantitative protein MS. To ensure added value of new medical tests and guarantee accurate test results, five key elements of test evaluation have been established by a working group within the European Federation for Clinical Chemistry and Laboratory Medicine. Moreover, it is emphasized to identify dinical gaps in the contemporary clinical pathways before test development is started. We demonstrate that quantitative protein MS tests that provide an additional layer of dinical information have robust performance and meet long-term desirable analytical performance specifications as exemplified by our own experience. Yet, the adoption of quantitative protein MS tests into medical laboratories is seriously hampered due to its complexity, lack of robotization and high initial investment costs. Successful and widespread implementation in medical laboratories requires uptake and automation of this next generation protein technology by the In-Vitro Diagnostics industry. Also, training curricula of lab workers and lab specialists should include education on enabling technologies for transitioning to precision medicine by quantitative protein MS tests.Keywords
Funding Information
- H2020 Marie Sklodowska-Curie Actions (843615)
- Leids Universitair Medisch Centrum
- Roche Diagnostics Netherlands B.V.
- Dutch Foundation for Clinical Chemistry and Laboratory Medicine
This publication has 98 references indexed in Scilit:
- Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in PlasmaMolecular & Cellular Proteomics, 2012
- A Protein Epitope Signature Tag (PrEST) Library Allows SILAC-based Absolute Quantification and Multiplexed Determination of Protein Copy Numbers in Cell LinesMolecular & Cellular Proteomics, 2012
- Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot databaseScientific Reports, 2011
- Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virusScientific Reports, 2011
- A Quantitative Study of the Effects of Chaotropic Agents, Surfactants, and Solvents on the Digestion Efficiency of Human Plasma Proteins by TrypsinJournal of Proteome Research, 2010
- Automated Detection of Inaccurate and Imprecise Transitions in Peptide Quantification by Multiple Reaction Monitoring Mass SpectrometryClinical Chemistry, 2010
- Introduction: Advances in Protein Analysis for the Clinical LaboratoryClinical Chemistry, 2010
- The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometryJournal of Immunological Methods, 2009
- Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2007
- System suitability in bioanalytical LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2007